New Jersey Senate Bill SR22

New Jersey 2022-2023 Regular Session

• Introduced: 1/18/22
• Refer: 1/18/22

Caption

Urges Congress to compel Department of Health and Human Services to fulfill its obligations pursuant to the National Childhood Vaccine Injury Act of 1986.

Impact

The bill aims to reinforce the regulations established by the NCVIA, which established a national vaccine program designed to ensure the safety and efficacy of vaccines. By urging the Secretary of DHHS to submit the overdue reports, the resolution seeks to increase the accountability of health authorities in monitoring vaccine safety. This could potentially alter the landscape of vaccine regulation and public confidence in immunization protocols. The resolution also points to the historical context of the NCVIA, which has been criticized for reducing incentives for manufacturers to prioritize vaccine safety.

Summary

Senate Resolution No. 22 (SR22) introduced in New Jersey urges the United States Congress to compel the Secretary of the U.S. Department of Health and Human Services (DHHS) to fulfill their obligations under the National Childhood Vaccine Injury Act of 1986 (NCVIA). The resolution emphasizes the importance of vaccine safety and the need for the DHHS to provide biennial reports to Congress detailing actions taken to improve vaccine safety. This resolution reflects the growing concern regarding vaccine safety and accountability following the provisions of the NCVIA that limit liability for vaccine manufacturers in the case of injury from vaccinations.

Contention

Supporters of SR22 argue that the resolution is necessary for protecting public health and ensuring that the DHHS remains vigilant in its oversight of vaccine safety. They contend that the previous lack of accountability has harmed public trust in vaccines. Conversely, critics may argue that increasing scrutiny and pressure on manufacturers could stifle innovation and exacerbate vaccine shortages. The tension between ensuring safety and maintaining supply is likely to be a key point of debate as SR22 progresses.